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The impact of chronic stress on the rat brain lipidome
TG Oliveira1,2, RB Chan3,4, FV Bravo1,2, A Miranda1,2, RR Silva1,2, B Zhou3,4, F Marques1,2, V Pinto1,2, JJ Cerqueira1,2, G Di Paolo3,4 and
N Sousa1,2
Chronic stress is a major risk factor for several human disorders that affect modern societies. The brain is a key target of chronic
stress. In fact, there is growing evidence indicating that exposure to stress affects learning and memory, decision making and
emotional responses, and may even predispose for pathological processes, such as Alzheimer’s disease and depression. Lipids are a
major constituent of the brain and speciﬁcally signaling lipids have been shown to regulate brain function. Here, we used a mass
spectrometry-based lipidomic approach to evaluate the impact of a chronic unpredictable stress (CUS) paradigm on the rat brain in
a region-speciﬁc manner. We found that the prefrontal cortex (PFC) was the area with the highest degree of changes induced by
chronic stress. Although the hippocampus presented relevant lipidomic changes, the amygdala and, to a greater extent, the
cerebellum presented few lipid changes upon chronic stress exposure. The sphingolipid and phospholipid metabolism were
profoundly affected, showing an increase in ceramide (Cer) and a decrease in sphingomyelin (SM) and dihydrosphingomyelin
(dhSM) levels, and a decrease in phosphatidylethanolamine (PE) and ether phosphatidylcholine (PCe) and increase in
lysophosphatidylethanolamine (LPE) levels, respectively. Furthermore, the fatty-acyl proﬁle of phospholipids and diacylglycerol
revealed that chronic stressed rats had higher 38 carbon(38C)-lipid levels in the hippocampus and reduced 36C-lipid levels in the
PFC. Finally, lysophosphatidylcholine (LPC) levels in the PFC were found to be correlated with blood corticosterone (CORT) levels.
In summary, lipidomic proﬁling of the effect of chronic stress allowed the identiﬁcation of dysregulated lipid pathways, revealing
putative targets for pharmacological intervention that may potentially be used to modulate stress-induced deﬁcits.
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INTRODUCTION
It is well established that prolonged exposure to stress triggers
deleterious effects on the brain structure and function. Indeed,
animals exposed to chronic stress have functional and morpho-
logical impairment in various brain regions, such as the hippo-
campus, the prefrontal cortex (PFC) and the amygdala.1,2 The
implications of these stress-induced alterations are multiple, with
an impact on learning and memory,3,4 decision making5 and emo-
tional responses.6 Moreover, stress has been linked to pathological
processes involved in highly prevalent diseases, such as Alzheimer’s
disease7 and depression.8 It is thus crucial to thoroughly under-
stand the molecular basis underlying the pathogenic effects of
chronic stress to identify novel targets for therapeutic interven-
tions against stress-induced alterations.
Stress response is characterized by a fast activation of the
sympathetic nervous system, followed by a slower activation of the
hypothalamic–pituitary–adrenal axis that culminates with the
release of glucocorticoids (GCs): cortisol in primates and corticoster-
one (CORT) in rodents. These hormones, believed to mediate a
signiﬁcant part of the pathologic effects of chronic stress, are
derived from cholesterol and typically bind to intracellular receptors.
There are two different corticosteroid receptors, the mineralocorti-
coid receptor and the GC receptor, which dimerize upon ligand
binding and translocate to the nucleus, regulating gene transcrip-
tion; the role of GC receptors in the membrane has been recognized
but their functional role is still being scrutinized.9 Because CORT has
a much higher afﬁnity for mineralocorticoid receptor than for GC
receptor, the latter is occupied only in the presence of elevated
CORT levels, such as those triggered by chronic stress.10 Importantly,
it has been shown that chronic unpredictable stress (CUS) leads to
major structural and functional hippocampal alterations,4,11,12 which
are, at least in part, mediated by increased levels of CORT.9,11
Therefore, it is critical to gain insights into the molecular
mechanisms responsible for the brain manifestations of chronic
stress and determine the contribution of CORT-dependent and
-independent processes to these manifestations. Growing evidence
suggests that stress/GCs may have an impact on brain lipid
metabolism. For instance, GCs have been shown to modulate brain
lipid signaling via stimulation of phospholipase A2 (PLA2), a key lipid
enzyme that cleaves membrane phospholipids into lysophospho-
lipids and arachidonic acid (AA), which are associated with
inﬂammatory processes.13 Importantly, it has been shown that
chronic stress also alters the expression of a lipid-modifying enzyme,
diacylglycerol (DG) lipase α, thus modulating the levels of DG and
2-arachidonoylglycerol in stress-susceptible brain regions.14 More-
over, chronic stress was shown to lead to an increase in ceramide
(Cer) levels in the mouse hippocampus.15
Given the implication of multiple facets of lipid signaling in
stress, we reasoned that a comprehensive mass spectrometry-
based lipidomic analysis of rodent brain under conditions of stress
would be both timely and informative. We evaluated the impact of
a 4-week CUS paradigm on various rat brain regions believed to
be affected by stress—the hippocampus, the PFC and the
amygdala—and as a control we analyzed the cerebellum, which
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is potentially a brain region not signiﬁcantly affected by stress.2
Overall, the PFC was the brain area with the highest degree of
changes induced by chronic stress. Speciﬁcally, sphingolipid
metabolism was affected, showing an increase in Cer and a
decrease in sphingomyelin (SM) and dihydrosphingomyelin
(dhSM) levels. Also, phospholipid metabolism was found to be
altered, with decreased phosphatidylethanolamine (PE) and ether
phosphatidylcholine (PCe) levels and an increase in lyso-
phosphatidylethanolamine (LPE) level. Furthermore, the fatty-
acid proﬁle of phospholipids and DG revealed that chronically
stressed rats had higher hippocampal 38 carbon (38C)-lipid levels
and decreased PFC 36C-lipid levels. Finally, our lipidomic analysis
revealed multiple brain lipid species levels to be correlated with
blood CORT levels.
MATERIALS AND METHODS
Animals and treatments
Experiments were conducted in accordance with local regulations
(European Union Directive 86/609/EEC) and National Institutes of Health
guidelines on animal care and experimentation. Adult (2 months old at the
beginning of the experiment) male Wistar rats (Charles River Laboratories,
Barcelona, Spain) were housed in groups of two under standard laboratory
conditions (lights were on from 0800 to 2000 hours; room temperature 22 °C;
ad libitum access to food and drink). In our experimental design we tested
four different conditions: (1) A group of 10 rats were handled daily and
served as controls. (2) A group of 10 rats were submitted to 4 weeks of a CUS
paradigm as described by Cerqueira et al.3 Brieﬂy, animals were exposed
once daily to a stressor (1 h day−1) of one of several aversive stimuli
(cold water (18 °C), vibration, restraint, overcrowding or exposure
to a hot air stream); the stressors were presented in random order for
the duration of the experiment. (3) A group of 10 animals were used as a
vehicle control group, with daily subcutaneous injections of sesame oil for
4 weeks. (4) A group of 10 animals underwent daily subcutaneous injec-
tions of synthetic CORT 40mg kg–1 (Sigma-Aldrich, St. Louis, MO, USA)
dissolved in sesame oil for 4 weeks. This CUS paradigm was previously shown
to result in persistently elevated plasma levels of CORT, the primary GC of the
rat.3
To ensure the effectiveness of the experimental procedures, serum CORT
levels were measured using a commercially available radioimmunoassay
kit (MP Biochemicals, Santa Ana, CA, USA) after the 4-week treatment
regimens (between 0800 and 0090 hours). The effectiveness of the CUS
paradigm was conﬁrmed with measurement of serum CORT levels, with a
58% increase in the CUS animals (control group 98.9 ± 11.8 ngml–1; CUS
group 154.1 ± 11.8 ngml–1; P= 0.029), and with behavioral analysis using
the elevated plus maze test (see below for methodological details), with a
48.5% decrease in the fraction of time spent in open arms for CUS animals
(control group 38.1 ± 10.2 s; CUS group 19.6 ± 11.8; P= 0.022). One serum
sample was lost during the experimental procedure.
Behavioral testing—elevated plus maze
The elevated plus maze test behavioral paradigm was used to test anxiety-
like behavior. The elevated plus maze test apparatus was made of black
polypropylene (ENV-560; MedAssociates, St. Albans, VT, USA) and consisted
of two opposite open arms (50.8 × 10.2 cm) and two enclosed arms
(50.8 × 10.2 × 40.6 cm) elevated 72.4 cm above the ﬂoor. The junction area
between the four arms measured 10 × 10 cm. A raised edge (0.5 cm) on the
open arms provided additional grip for the rats. Rats were placed
individually in the center of the maze facing a closed arm and were
allowed 5min of free exploration. Behavioral parameters were recorded
with the use of an infrared photobeam system connected to a computer
with speciﬁc software (MedPCIV, MedAssociates) and posteriorly conﬁrmed
by video analysis. After each trial, the maze was cleaned with 10% ethanol.
The percentage of time spent in the open arms was taken as an index of
anxiety-like behavior.16
Annotation of lipid species
Lipids are annotated with subclass name followed by total fatty-radyl
carbons and unsaturation as needed. DG and TG species are annotated
similarly, with the addition of fatty-acyl carbon and unsaturation of the
product ion. All measured sphingolipids contained d18:1 long-chain base
(excepting dhSM species, containing a d18:0 base). All measured
acyl-phosphatidylserine (APS) species contained C16:0N-linked fatty-acyl
chains.
Analysis of lipids using high-performance liquid
chromatography–mass spectrometry
Upon completion of behavioral testing, the animals were killed, macro-
dissection of the hippocampus, PFC, amygdala and cerebellum was
performed, and all tissue samples were immediately collected in tubes,
drop-freezed in liquid nitrogen and subsequently stored at − 80 °C for
further processing. Samples from each brain area were processed simul-
taneously. Tissue lipid extracts were prepared using a modiﬁed Bligh/Dyer
procedure, spiked with appropriate internal standards, and analyzed using
a 6490 Triple Quadrupole LC/MS system (Agilent Technologies, Santa Clara,
CA, USA). Glycerophospholipids and sphingolipids were separated with
normal-phase HPLC as before,17,18 with a few changes. An Agilent Zorbax
Rx-Sil column (inner diameter 2.1 × 100mm) was used under the following
conditions: mobile phase A (chloroform:methanol:1 M ammonium hydrox-
ide, 89.9:10:0.1, v/v) and mobile phase B (chloroform:methanol:water:
ammonium hydroxide, 55:39.9:5:0.1, v/v); 95% A for 2 min, linear gradient
to 30% A over 18min and held for 3 min, and linear gradient to 95% A over
2min and held for 6 min. Sterols and glycerolipids were separated with
reverse-phase HPLC using an isocratic mobile phase as before17 except
with an Agilent Zorbax Eclipse XDB-C18 column (4.6 × 100mm). Individual
lipid species were measured by multiple reaction monitoring transitions
and lipid concentration was calculated by referencing to appropriate
internal standards: D5-cholesterol, CE 17:0, 4ME 16:0 diether DG, D5-TG
16:0/18:0/16:0, PA 14:0/14:0, PC 14:0/14:0, PE 14:0/14:0, PG 15:0/15:0, PS
14:0/14:0, LPC 17:0, LPE 14:0, LPI 13:0, BMP 14:0/14:0, SM d18:1/12:0, dhSM
d18:0/12:0, Cer d18:1/17:0, GalCer d18:1/12:0, LacCer d18:1/12:0 and Sulf
d18:1/17:0 (Avanti Polar Lipids, Alabaster, AL, USA). PI 16:0/16:0 was
purchased separately (Echelon Biosciences, Salt Lake City, UT, USA). Some
lipid classes did not have commercially available internal standards and
hence these lipids were referenced to standards that are closely eluted in
the liquid chromatography–mass spectroscopy method: Ether-linked
species were normalized to corresponding acyl-linked standards: NAPS
to PS 14:0/14:0 and GM3 to PI 16:0/16:0. Lipid concentration was
normalized by molar concentration across all species for each sample,
and the ﬁnal data are presented as mean mol%.
Gene expression measurements by qRT-PCR
Total RNA was extracted from PFC using the TripleXtractor (Grisp, Porto,
Portugal), following the manufacturer’s instructions. RNA quality and
quantiﬁcation was assessed in the NanoDrop ND-1000 (NanoDrop, Thermo
Scientiﬁc, Wilmington, DE, USA) and a total of 1 µg of RNA from each
sample was reverse transcribed into cDNA using the iScriptTM cDNA
Synthesis Kit (Bio-Rad Laboratories, Hercules, CA, USA) following the
manufacturer’s instructions. Primers used to measure the expression levels
of selected mRNA transcripts of Rattus norvegicus and Mus musculus
(conserved sequence) by qRT-PCR were designed using Primer3 software,
on the basis of the respective GenBank sequences, conﬁrming intron
spanning using BLAT software. The reference gene glyceraldehyde
3-phosphate dehydrogenase was used as the internal standard for the
normalization of the selected transcript expression. All gene accession
numbers and primer sequences are provided in Supplementary Table 1.
qRT-PCR was performed on a CFX 96TM real-time system instrument (Bio-
Rad Laboratories), with SsoFastTM EvaGreen Supermix (Bio-Rad Labora-
tories), according to the manufacturer’s instructions, using equal amounts
of cDNA from each sample. The cycling parameters were one cycle at 95 °C
for 1 min, followed by 39 cycles at 95 °C for 15 s, annealing temperature
(primer speciﬁc) for 20 s and 72 °C for 20 s, ﬁnishing with one cycle at 65 °C
to 95 °C, with an increment of 0.5 °C, for 5 s (melting curve). Product
ﬂuorescence was detected at the end of the elongation cycle. All melting
curves exhibited a single sharp peak at the expected temperature.
Data analysis and presentation
All lipid species and subclasses analyzed were found to have equal
variance (data not shown) and were analyzed with an unpaired two-tailed
Student t-test. CORT levels and elevated plus maze test data were analyzed
with an unpaired one-tailed Student t-test in all cases; *P⩽ 0.05; **P⩽ 0.01;
***P⩽ 0.001. Correlation data analysis was performed using the linear
regression model and coefﬁcient of determination and values are
expressed as R2. Error bars represent the s.e.m. in all cases.
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RESULTS
Chronic stress affects preferentially the PFC lipidome
In the control group, different rat brain areas exhibited different
lipidomic proﬁles in the absence of treatment. Considering the
major lipid species, we observed that free cholesterol is the most
abundant lipid in all regions analyzed, presenting higher levels
in the cerebellum and proportionally lower levels in the PFC.
In contrast, PC, the second most abundant lipid, displayed an
opposite pattern with relatively lower levels in the cerebellum and
higher levels in the PFC. On a second level of magnitude, SM, PE,
plasmalogen PE, PI, PS, Sulf, CE, DG, dhSM and HexCer presented
moderately higher levels compared with the remaining minor
subclasses evaluated (Figure 1).
Overall, the PFC was the area with the highest degree of
changes induced by chronic stress, with sphingolipid metabolism
being the most affected (Figure 1 and Supplementary Figure 1).
Considering the total lipid species per lipid class, we found that, in
the PFC, CUS led to a sphingolipid imbalance with an increase in
Cer and lactosylceramide (LacCer) levels and a decrease in SM and
dhSM levels. Other lipid classes were also affected, as observed by
a decrease in PE and ether PC (PCe) levels and an increase in LPE
and triacylglycerol (TG) levels (Figure 1 and Supplementary
Figure 1). A more profound lipid species analysis of the major
altered lipid subclasses (Cer, LacCer, SM, dhSM and PE) in the PFC
revealed that there was an overall coherent effect on the majority
of the analyzed lipid species (Figure 2).
CUS led to a similarly altered sphingolipid pattern in the hippo-
campus, with an increase in Cer and a decrease in SM levels. Other
lipid changes such as an increase in PI levels and decreased APS
levels were also observed (Figure 1 and Supplementary Figure 1).
Interestingly, the amygdala presented only minor alterations,
with increased levels of 2-hydroxy N-acyl sulfatide [Sulf(2OH)], a
myelin lipid, and no signiﬁcant differences in the cerebellum
(Figure 1 and Supplementary Figure 1).
Fatty-acid lipid composition is affected by chronic stress
Brain function relies on the homeostasis of cellular membranes,
and its perturbation might partially explain the neuronal deﬁcits
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Figure 1. Chronic stress alters the lipid composition in the rat brain. Lipid composition of different areas of the brain of adult rats submitted to
4 weeks of chronic unpredictable stress (CUS, red bars) compared with control rats (black bars). Four brain regions were analyzed: the
hippocampus (a), the prefrontal cortex (PFC) (b), the amygdala (c) and the cerebellum (d). Values shown are normalized to measured molar
lipid concentration. 24-OHC, 24(S)-hydroxycholesterol; APS, acyl-phosphatidylserine; BMP, bis(monoacylglycero)phosphate; CE, cholesteryl
ester; Cer, ceramide; DG, diacylglycerol; dhSM, dihydrosphingomyelin; GM3, monosialodihexosylganglioside; HexCer, hexosylceramide; LacCer,
lactosylceramide; LPC, lysophosphatidylcholine; LPCe, ether lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPEp, plasmalogen
LPE; LPI, lysophosphatidylinositol; PA, phosphatidic acid; PC, phosphatidylcholine; PCe, ether phosphatidylcholine; PE, phosphatidylethano-
lamine; PEp, plasmalogen PE; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin; Sulf, sulfatides;
Sulf(2OH), 2- hydroxy N-acyl sulfatide; TG, triacylglycerol. N= 10 per group. Results are presented as mean and bars as s.e.m. *P⩽ 0.05;
**P⩽ 0.01; ***P⩽ 0.001 by the unpaired two-tailed Student t-test.
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observed in various neurological conditions. Both the carbon
chain length and the degree of saturation of the fatty-acyls that
are part of membrane lipids determine membrane biophysical
properties. Therefore, the modulation of the composition of
its fatty-acyl chains can potentially affect neuronal functioning,
at least in part through altered function of membrane-bound
proteins.19,20
In our study we performed another level of analysis focusing on
the fatty-acyl chain proﬁle. Our data show that CUS led to a
signiﬁcant alteration in the fatty-acyl chain proﬁle of phospho-
lipids and DG, with increased levels of long-chain fatty-acyls with
38C and an increase in polyunsaturated fatty-acyls with four
double bonds in the hippocampus (Figure 3). Whereas in the PFC
we observed a decrease in 36C fatty-acyls, in the cerebellum we
observed an increase in its levels. Interestingly, with regard to the
effects of CUS in sphingolipid composition, only the PFC was
affected with an increase in short-chain fatty-acyls (16C) and a
decrease in medium-length (20C) fatty-acyls (Figure 3).
Speciﬁc lipid species are correlated with blood CORT levels after
chronic stress exposure
The stress response is characterized by an acute activation of the
sympathetic nervous system, followed by a slower activation of
the hypothalamic–pituitary–adrenal axis that culminates with the
release of GCs, such as cortisol in primates and CORT in rodents.
To test which lipid species were associated with serum CORT
levels, we performed a full-scale unbiased correlation analysis
between serum levels of this hormone and abundance of the 359
quantiﬁable lipid species in each brain region. We deﬁned a cutoff
for the correlation index of 0,4 (R2) in order to limit the hits in our
analysis (Figure 4a). We found that CORT serum levels were
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Figure 2. Chronic stress has a signiﬁcant impact on sphingolipid and PE metabolism in the prefrontal cortex (PFC). PFC lipid species
composition of adult rats subjected to 4 weeks of chronic unpredictable stress (CUS, red bars) compared with control rats (black bars)
submitted to handling. Analysis showed increases in several Cer (a) and all lactosylceramide (b) species and decreases in many SM (c), dhSM
(d) and PE (e) species. y values expressed as relative levels to control animals. Cer, ceramide; dhSM, dihydrosphingomyelin; LacCer,
lactosylceramide; PE, phosphatidylethanolamine; SM, sphingomyelin. N= 10 per group. Results are presented as mean and bars as standard
error of the mean. *P⩽ 0.05; **P⩽ 0.01; ***P⩽ 0.001.
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directly correlated with PFC levels of total levels of lysophos-
phatidylcholine (LPC) (Figure 4b1) and inversely correlated with
total SM levels (Figure 4b2). Moreover, various LPC species in PFC,
LPC 20:4 (Figure 4b3), LPC 20:3 (data not shown), LPC 16:0 (data
not shown) and PA 40:5 (Figure 4b4) levels were found to be
directly correlated with serum CORT levels. In the hippocampus
we found a single correlation hit for LPC 20:4 (Figure 4c). In the
amygdala LPC 20:4 (Figure 4e) was also found to be correlated
with blood CORT levels, as well as phosphatidylserine (PS) 38:1
levels (data not shown). Finally, no correlation hits were found in
the cerebellum.
Common lipid changes after chronic stress and exogenous CORT
exposure
In order to gain further insight into which lipid species alterations
induced by CUS are in fact mediated by CORT, we evaluated the
impact of exogenous administration of CORT in the PFC lipid
proﬁle and the lipid-induced alterations common to both the CUS
group and the CORT-injected animals. We found a common
increase in Cer 18:1, PG 36:1, phosphatidic acid (PA) 40:5, PA 40:6,
LPC 16:0 and a common decrease in multiple PC, PCe and PE lipid
species (Figure 5).
Stress-induced lipid changes in the PFC are independent of
changes in enzymatic expression levels
In light of our comprehensive lipid analysis, and in accordance
with previous studies showing altered transcriptomic levels
in the PFC in a mouse model of chronic stress,21 one possibility
was that the lipid changes we observed in the PFC after exposure
to CUS were due to expression level alterations of enzymatic
lipid modulators. We measured mRNA levels of some of our
most likely candidates, namely, Smpd1—acidic sphingomyelinase,
* *
**
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*
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Figure 3. Altered fatty-acid composition after chronic unpredictable stress exposure (CUS) in different rat brain regions. Analysis of fatty-acyl
composition of diacyl-glycerophospholipids and DG species by total carbon chain length (a1, b1, c1, d1), total degree of unsaturation (a2, b2,
c2, d2) and sphingolipid N-acyl chain lengths (a3, b3, c3, d3). Values are expressed as mol%+s.e.m of included lipid species. Lipid tissue
extracts from the hippocampus (a1–a3), prefrontal cortex (PFC) (b1–b3), amygdala (c1–c3) and cerebellum (d1–d3) were analyzed. Adult rats
subjected to 4 weeks of CUS (red bars) compared with control rats (black bars) submitted to handling. N= 10 per group. *P⩽ 0.05; **P⩽ 0.01;
***P⩽ 0.001.
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Smpd2—neutral sphingomyelinase, Pla2g2C, Pla2G4a, Pla2g5,
Pla2g6, Pld1 and Pld2 (Supplementary Figure 2). We found no
differences in the expression levels of our candidate enzymatic
hits, suggesting that at least some of the lipid changes we found
are independent of expression level regulation of the main
catalytical enzymes of our candidate lipid pathways.
DISCUSSION/CONCLUSIONS
In the present study we performed a detailed lipidomic analysis to
understand the impact of chronic stress in distinct brain areas. So
far, very few studies have analyzed the impact of either acute22 or
chronic stress23,24 in lipid signaling using a lipidomic approach,
the focus has been predominantly on the role of endocannabi-
noids as modulators of stress-associated pathways.25
This thorough analysis of the rodent brain lipidome unmasks
the PFC as a key target of stress, with the highest degree of lipid
changes induced by chronic stress. Speciﬁcally, in the PFC,
sphingolipid metabolism was highly affected with increased Cer
and decreased SM and dhSM levels, and phospholipid metabolism
with decreased PE and increased LPE levels. This region vulnera-
bility ﬁts with previous studies showing that the PFC is the brain
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Figure 4. Speciﬁc lipid species brain levels are directly correlated with blood corticosterone (CORT) levels. (a) Correlation levels between all
lipid species analyzed and blood CORT levels. Lipid species are grouped per lipid class, and rat brain areas are represented with different
colored dots: hippocampus (Hip—black), prefrontal cortex (PFC—red), amygdala (Amyg—gray) and cerebellum (Cereb—pink). R2 levels are
represented from (−1) to (+1), with positive values indicating a positive correlation and negative values indicating a negative correlation. (b–e)
For each brain area analyzed, PFC (b), hippocampus (c) and amygdala (d), the major positive lipid species CORT-correlation hits are
represented. Not all positive hits are represented in the ﬁgure. Adult rats submitted to 4 weeks of chronic unpredictable stress (CUS, red dots)
and handled controls (black dots) are represented. (b1–4) Selected lipid species with a higher degree of correlation index in the PFC. (c1)
Selected lipid species with a higher degree of correlation index in the hippocampus. (d) Selected lipid species with a higher degree of
correlation index in the amygdala. 24-OHC, 24(S)-hydroxycholesterol; APS, acyl-phosphatidylserine; BMP, bis(monoacylglycero)phosphate; CE,
cholesteryl ester; Cer, ceramide; DG, diacylglycerol; dhSM, dihydrosphingomyelin; GM3, monosialodihexosylganglioside; HexCer,
hexosylceramide; LacCer, lactosylceramide; LPC, lysophosphatidylcholine; LPCe, ether lysophosphatidylcholine; LPE, lysophosphatidyletha-
nolamine; LPEp, plasmalogen LPE; LPI, lysophosphatidylinositol; PA, phosphatidic acid; PC, phosphatidylcholine; PCe, ether PC; PE,
phosphatidylethanolamine; PEp, plasmalogen PE; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; SM,
sphingomyelin; Sulf, sulfatides; Sulf(2OH), 2-hydroxy N-acyl sulfatide; TG, triacylglycerol. N= 10 per group.
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region displaying major lipid alterations after the use of maproti-
line, an antidepressant.26 In line with the PFC changes, we found
that the hippocampus lipid proﬁle also displayed sphingolipid
metabolic changes and increased PI levels. The similar pattern of
lipid changes is interesting, as previous studies demonstrated the
PFC and the hippocampus to be functionally and structurally
impaired after chronic stress exposure.1,2 The lipid alterations
found in our study suggest that sphingolipid modulating enzymes
may be dysregulated in both regions, either due to increased
sphingomyelinase (SMase) activity (which catalyzes the hydrolysis
of SM and dhSM into Cer and dhCer, respectively) or decreased
SM synthase activity (which catalyzes the opposite reaction).27
Alternatively, other pathways for Cer formation, such as de novo
synthesis or hydrolysis of more complex sphingolipids, cannot be
excluded as potential contributors to the observed increase in Cer
levels.28 This is in accordance with what was shown in other
studies, in which hippocampal levels of Cer were found to be
increased in a CUS mouse model.15 Importantly, these sphingo-
lipid alterations can potentially alter the organization of speciﬁc
lipid microdomains, such as lipid rafts, with implications for brain
function.29
The combination of decreased PE and increased LPE levels
suggests a hyperactive state of a PLA2 isoform30 in the PFC after
CUS exposure. Interestingly, decreased levels and pharmacologic
inhibition of acidic SMase prevented CUS-induced alterations,15
and the downregulation of calcium-independent PLA2 (iPLA2)
blocked both the behavior-induced alterations and the PFC lipid
proﬁle owing to maprotiline chronic treatment.31 Also noticeable
is the observation that PLA2 activation is associated with increased
inﬂammation. In a genetically induced model of neurodegenera-
tion, it was shown that speciﬁc lysophospholipids were respon-
sible for microglial activation and that cytosolic PLA2 (cPLA2)
inhibition protected neurons from associated local inﬂammation
and glutamate-mediated neurotoxicity.32 Besides comparing the
individual species we also analyzed the fatty-acyl chain proﬁle of
both phospholipids/DG and sphingolipids. In summary, we found
that CUS led to a decrease in 36C fatty-acyl phospholipids/DG
levels in the PFC and to an increase in 38C and four double-bond
polyunsaturated phospholipids/DG levels in the hippocampus.
Interestingly, the hippocampal data indicate the possible accumu-
lation of phospholipids containing AA (20:4) as part of the fatty-
acyl composition. This is supported by ﬁndings in a depressive-like
rat model in which a similar pattern of increased levels of
AA-containing phospholipids and decreased docosahexaenoic
acid (DHA)-containing phospholipids occurred in the PFC.33,34
Also, diets rich in polyunsaturated fatty acids (PUFA), such as ﬁsh
oil diet, showed an increase in DHA-containing phospholipids PC
40:6 and PC 38:6 and a decrease in AA-containing phospholipids
PC 38:4 and PC 36:4.35 The DHA-treated rats had decreased levels
of AA-containing phospholipids with concomitant prevention of
the lipid alterations induced by aging.36 Finally, diets deﬁcient in
n-3 PUFA led to decreased DHA levels and increased DHA half-life
due to a downregulation of iPLA2 levels and upregulation of both
secreted PLA2 (sPLA2) and cPLA2 in the frontal cortex.37 Overall,
our data, and previous studies, suggest that AA accumulation in
the hippocampus might be deleterious, whereas DHA accumula-
tion in the frontal cortex might be protective in the context of
neurodegeneration. As it was previously proposed that cPLA2
preferentially releases AA and that iPLA2 preferentially cleaves
DHA-containing phospholipids,38 it is plausible that there is a
dysregulation of iPLA2 in the PFC and of cPLA2 in the hippo-
campus (as discussed in37 and38). Moreover, patients with
depression were found to have increased ratio blood levels of
n-6/n-3 PUFA,39 and chronic stress in rodents altered lipoprotein
blood and liver metabolism.40,41 Of note, circulating FA can reach
the brain and be incorporated in the cells of the central nervous
system.42 Therefore, all these aspects are of critical relevance for
our understanding of the lipid metabolism crosstalk between the
central nervous system and the periphery in physiological and
pathological conditions, and should be addressed in future
studies. As elevations in CORT levels are a critical element in the
stress response, we tested which of the stress effects in brain
lipidomics could be attributed to hypercortisolemia. First, with an
unbiased strategy, we identiﬁed which lipid species had a higher
degree of correlation with endogenous CORT levels; second, we
identiﬁed the common alterations in the PFC lipid proﬁle of both
CUS- and CORT-injected animals. In the PFC we found that CORT
serum levels were directly correlated with multiple LPC species
levels, and inversely correlated with total SM levels. Interestingly,
we found that, speciﬁcally, LPC 20:4 was found as a positive
correlation hit in all brain areas studied except the cerebellum.
This is in accordance with the also observed accumu-
lation of AA-containing phospholipids, which is thought to have
a deleterious effect. Among the few studies addressing the role of
LPC 20:4, it was shown that it can promote inﬂammatory events
through the donation of AA, which is proposed to be released in a
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Figure 5. Common prefrontal cortex (PFC) lipid changes after chronic unpredictable stress (CUS) and exogenous corticosterone (CORT)
exposure. Common altered lipid species composition in the PFC of adult rats submitted to 4 weeks of CUS or (red bars) to 4 weeks of
subcutaneous CORT (40 mg kg–1) injections (pink bars). Results are expressed as percentual change ratio with each control group; for the CUS
the ratio values are relative to control handled animals; for the CORT-injected animals the ratio values are relative to vehicle-injected animals.
Cer, ceramide; LPC, lysophosphatidylcholine; PA, phosphatidic acid; PC, phosphatidylcholine; PCe, ether PC; PE, phosphatidylethanolamine;
PEp, plasmalogen PE; PG, phosphatidylglycerol. N= 10 per group. Results are presented as mean and bars as s.e.m. *P⩽ 0.05; **P⩽ 0.01;
***P⩽ 0.001.
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cPLA2-dependent way.43 Moreover, both CUS- and CORT-injected
animals had increased levels of Cer 18:1 and LPC 16:0 and
decreased levels in multiple PC, PCe and PE species, suggesting
that CORT might be leading to an activation of PLA2 and SMase in
the PFC of stressed animals. Interestingly, PA 40:5 PFC levels were
directly correlated with endogenous blood CORT levels, and PA
40:5 and PA 40:6 levels were both increased in the PFC of CUS-
and CORT-injected animals, which suggests that phospholipase D
(PLD)-dependent pathways might also be activated by GCs. This is
in accordance with previous reports showing increased PLD
activity after treatment with a synthetic corticosteroid.44 The latter
is likely to result from the GC-induced calcium inﬂux,45 a known
activator of PLD.46 Interestingly, PLD activation was also shown to
be detrimental in other neurodegeneration conditions.47,48
In summary, herein we identiﬁed the lipid alterations induced
by chronic stress and CORT in target brain areas. Our data show
that the metabolism of sphingolipids and phospholipids is signiﬁ-
cantly altered by stress in both the PFC and the hippocampus,
suggesting SMase, PLA2 and PLD as potential therapeutical
targets for stress-related disorders. These alterations in lipid signal-
ing pathways have several implications in physiological mecha-
nisms, such as neurogenesis and synaptic plasticity, known to be
implicated in several stress-related disorders, such as emotional
disorders,15,49–51 and eventually in other psychiatric disorders,
such as schizophrenia.51–54 Given that there are different SMase,
PLA2 and PLD isozymes, future lipidomic studies addressing the
impact of lipid signaling-targeted therapeutical drugs will provide
pharmacological mechanistic insights into choosing the best
candidate drug in a given pathological condition. Also, other non-
pharmacological approaches, such as lifestyle changes and thera-
peutic diets with previously predetermined brain lipid proﬁles,
may prove of interest in these conditions.
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